文献速递系统性红斑狼疮

活动性系统性红斑狼疮患者T细胞中富含丝氨酸/精氨酸剪接因子1表达降低导致RasGRP1和DNA甲基转移酶1表达减少

Decreased Expression of Serine/Arginine-Rich Splicing Factor 1 in T Cells From Patients With Active Systemic Lupus Erythematosus Accounts for Reduced Expression of RasGRP1 and DNA Methyltransferase 1.
PubMed 文献 · Arthritis Rheumatol · 2018-10-01

本研究检测45例系统性红斑狼疮(SLE)患者与18名健康对照T细胞中SRSF1、野生型RasGRP1及DNMT1的表达,发现SLE患者SRSF1表达显著降低且与疾病活动度负相关,SRSF1可直接结合RasGRP1 mRNA外显子11并调控其可变剪接,SLE T细胞过表达SRSF1可恢复RasGRP1并诱导DNMT1/白介素2表达。

要点

  • SLE患者T细胞SRSF1表达显著低于健康对照,且与疾病活动度呈负相关。
  • SRSF1直接结合RasGRP1 mRNA外显子11,沉默SRSF1增加RasGRP1-AS/WT比值并降低RasGRP1蛋白。
  • SLE T细胞过表达SRSF1可恢复RasGRP1,进而诱导DNMT1/白介素2表达。

核心结论

  • SRSF1调控RasGRP1的可变剪接及后续蛋白表达,可变剪接通过控制多个基因表达在SLE患者T细胞功能异常中起核心作用。

研究设计与样本

  • 研究纳入45例SLE患者和18名健康受试者,检测T细胞中SRSF1、野生型RasGRP1和DNMT1的表达水平。
  • 采用寡核苷酸-蛋白拉下实验评估SRSF1与RasGRP1 mRNA外显子11的直接结合。
  • 分别用SRSF1特异性小干扰RNA处理健康T细胞、用SRSF1表达载体处理SLE T细胞后评估mRNA/蛋白表达。

主要发现

  • SLE患者T细胞SRSF1表达水平显著低于健康受试者,且与疾病活动度呈负相关、与RasGRP1-WT和DNMT1水平呈正相关。
  • SRSF1可直接结合RasGRP1 mRNA外显子11。
  • 沉默人T细胞中SRSF1导致RasGRP1-AS与RasGRP1-WT比值升高、RasGRP1蛋白水平降低。
  • SLE T细胞中过表达SRSF1引起RasGRP1恢复,进而诱导DNMT1/白介素2表达。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: T cells from systemic lupus erythematosus (SLE) patients have reduced protein levels of RasGRP1, a guanine nucleotide exchange factor for Ras, and increased transcript of alternatively spliced (AS) forms lacking exon 11. Serine/arginine-rich splicing factor 1 (SRSF1) binds pre-messenger RNA (pre-mRNA) to regulate AS forms of several genes, including CD3ζ in SLE T cells. This study was undertaken to assess whether SRSF1 controls the expression of RasGRP1 in T cells from patients with SLE. METHODS: We studied T cells from 45 SLE patients and 18 healthy subjects. Expression levels of SRSF1, wild-type (WT) RasGRP1, and DNA methyltransferase 1 (DNMT1) were assessed by quantitative polymerase chain reaction. Direct binding of SRSF1 to exon 11 of RasGRP1 mRNA was evaluated with an oligonucleotide-protein pulldown assay. Healthy T cells and SLE T cells were treated with SRSF1-specific small interfering RNA or SRSF1 expression vector, respectively, and then evaluated for mRNA/protein expression. RESULTS: SRSF1 expression levels were significantly lower in T cells from SLE patients compared to those from healthy subjects, and correlated inversely with disease activity and positively with levels of RasGRP1-WT and DNMT1. SRSF1 bound directly to exon 11 of RasGRP1 mRNA. Silencing of SRSF1 in human T cells led to increased ratios of RasGRP1-AS to RasGRP1-WT and decreased levels of RasGRP1 protein, whereas overexpression of SRSF1 in SLE T cells caused recovery of RasGRP1, which in turn induced DNMT1/interleukin-2 expression. CONCLUSION: SRSF1 controls the alternative splicing of RasGRP1 and subsequent protein expression. Our findings extend evidence that alternative splicing plays a central role in the aberrant T cell function in patients with SLE by controlling the expression of multiple genes.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Kono M, Kurita T, Yasuda S, et al. Decreased Expression of Serine/Arginine-Rich Splicing Factor 1 in T Cells From Patients With Active Systemic Lupus Erythematosus Accounts for Reduced Expression of RasGRP1 and DNA Methyltransferase 1. Arthritis Rheumatol. 2018. PMID: 29905030. doi:10.1002/art.40585

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。